Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1593 of 6351
-
New drug zanzalintinib aims to shrink thyroid tumors before surgery
Disease control Recruiting nowTo look at the effectiveness of zanzalintinib, followed by surgery, in treating advanced thyroid cancer. The safety of this treatment will also be studied.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Fish skin used in groundbreaking gender surgery study
Symptom relief Recruiting nowBottom gender affirming surgery is one of the key steps towards aligning the physical appearance and gender identity in transgender women. This surgery not only helps in reducing gender dysphoria but also significantly improves the quality of life and psychological well-being of …
Sponsor: University Hospitals Cleveland Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New drug FORX-428 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe goal of this interventional study is to evaluate the safety and tolerability of escalating doses of FORX-48 as monotherapy in patients with select advanced solid tumors with BRCA1/2 mutations or other DDR deficiencies or high replication stress, and to determine the maximum t…
Phase 1 • Sponsor: FoRx Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could CBD help curb alcohol cravings? new trial investigates
Disease control Recruiting nowAlcohol addiction (AD) is a chronic relapsing disorder with currently limited pharmacological treatment options. Alcohol craving, a hallmark symptom of AD that drives relapse in patients, is only insufficiently treated by existing medication. One promising new compound for the tr…
Phase 2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a simple antibiotic course fight oral cancer from the inside?
Disease control Recruiting nowThe goal of this phase II single arm clinical study is to evaluate the effect of antibiotics (metronidazole) and oral chlorhexidine (CHX) in reducing the bacteria load within tumors of patients undergoing surgery for oral cancer.
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New cancer drug VIR-5525 enters first human trials for EGFR-Positive tumors
Disease control Recruiting nowThis Phase 1, first-in-human (FIH), dose-escalation and dose-expansion study is designed to evaluate the safety, PK, and preliminary anti-tumor activity of VIR-5525 as a monotherapy and in combination with pembrolizumab in participants with solid tumors that are known to express …
Phase 1 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New cancer drug SHR-4506 enters first human tests
Disease control Recruiting nowThe study is being conducted to evaluate the safety and tolerability of SHR-4506 Injection in patients with malignant tumors and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD).
Phase 1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Mind over paralysis: can thinking about walking reboot the brain?
Knowledge-focused By invitation onlySpinal cord injury (SCI) is a highly debilitating pathology, associated with the loss of sensorimotor functions, autonomy and quality of life. Although there is currently no cure, brain-machine interfaces (BMI) have been used as a method of SCI rehabilitation. BMIs use neurophysi…
Sponsor: José Gabriel da Silva Figueiredo • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Can a psychedelic drug help heal trauma? a small trial puts psilocybin to the test
Symptom relief Recruiting nowThis is an open-label pilot study designed to evaluate the safety, tolerability, and preliminary clinical effects of psilocybin-enhanced trauma-focused psychotherapy in individuals with post-traumatic stress disorder (PTSD). Participants will receive a structured therapeutic pro…
Early phase 1 • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
New study aims to find best CMV prevention for kidney transplant patients
Prevention Recruiting nowThis is a prospective, randomized multicenter trial of preemptive therapy (PET) vs. antiviral prophylaxis (AP) for prevention of cytomegalovirus (CMV) disease in adult D+R- kidney transplant recipients (KTR). Patients meeting study eligibility criteria and who have provided infor…
Phase 3 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New drug combo aims to prevent dangerous transplant complication
Disease control Recruiting nowThe goal of this clinical research study is to compare the effects of these drug combinations (cyclophosphamide, sirolimus, and MMF vs cyclophosphamide, sirolimus, and ruxolitinib) on the prevention of GVHD after a stem cell transplant.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New oral drug targets Hard-to-Treat cancers with missing gene
Disease control Recruiting nowThis is a first-in-human (FIH), multicenter, non-randomized, openlabel, phase 1 study of ABSK131 in patients with MTAP-Deficient Advanced/Metastatic Solid Tumors to evaluate the safety, tolerability, PK, and preliminary antitumor efficacy.
Phase 1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Blood test could revolutionize TB treatment monitoring
Knowledge-focused Recruiting nowTuberculosis (TB) is a leading infectious cause of death worldwide. Current strategies for monitoring TB treatment response are culture dependent and insensitive. New methods of assessing treatment response in vivo could inform new drug development and other treatment strategies.…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood 'Cleaning' may bring relief to High-Altitude sufferers
Symptom relief Recruiting nowThe study aims to explore the efficacy and safety of erythrocytapheresis in chronic mountain sickness
Sponsor: Third Military Medical University • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can mapping symptoms reveal how student mental health unravels?
Knowledge-focused Recruiting nowTo fully grasp mental health, it is essential to understand and assess it by considering all the factors that affect it: family environment, school environment, emotional relationships, living conditions, social networks, etc. The symptom network approach takes into account a ne…
Sponsor: O-Kidia • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Could sound waves boost brain health in Alzheimer's?
Symptom relief Recruiting nowTPS is a non-invasive therapeutic modality that uses focused, low-energy pulse stimulation to stimulate tissue regeneration and reduce inflammation. In the context of neurological disorders, it is hypothesized that TPS can modulate neuronal activity, enhance synaptic plasticity, …
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 26, 2026 18:08 UTC
-
Could a smartphone app help your heart and your memory after a procedure for AFib?
Disease control Recruiting now"Atrial fibrillation (AF) is known as the most common sustained arrhythmia observed in clinical situation. Pulse Field Ablation (PFA) is a recently introduced, effective atrial fibrillation (AF) ablation modality. PFA is safe for treating patients with AF. The "MANIFEST-17K" inte…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Stanford tests dream therapy under anesthesia for PTSD relief
Symptom relief Recruiting nowThe goal of this study is to test whether anesthesia-induced dreaming can help alleviate symptoms of PTSD in an (1) open-label trial (Phase I) and (2) double-blind, randomized controlled trial (Phase II) in a non-surgical setting. The investigators predict that inducing and susta…
Phase 2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could ditching diets boost Women's body image and Well-Being?
Symptom relief CompletedThe goal of this clinical trial is to evaluate whether a non-diet nutrition education program can improve eating behaviors, body image, and well-being in normal-BMI women aged 19-35 years. The main questions it aims to answer are: * Does participation in an 8-week non-diet nutri…
Sponsor: Tuğba TÜRKCAN • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Experimental enzyme injection aims to tame PKU's toxic amino acid
Disease control Recruiting nowThe primary objective of this clinical trial is to evaluate the safety and tolerability of single and multiple administrations of PL54 in patients aged 18-55 years. The key questions it aims to answer include: How safe and tolerable is PL54 in PKU patients following single and m…
Phase 1 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC